236 related articles for article (PubMed ID: 15198790)
1. How much is enough and who says so?
Kelleher CJ; Pleil AM; Reese PR; Burgess SM; Brodish PH
BJOG; 2004 Jun; 111(6):605-12. PubMed ID: 15198790
[TBL] [Abstract][Full Text] [Related]
2. Use of the short form of King's Health Questionnaire to measure quality of life in patients with an overactive bladder.
Homma Y; Uemura S
BJU Int; 2004 May; 93(7):1009-13. PubMed ID: 15142153
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three disease-specific quality-of-life questionnaires (Bristol Female Lower Urinary Tract Symptoms, Incontinence Quality of Life and King's Health Questionnaire) in women with stress urinary incontinence.
Oh SJ; Ku JH
Scand J Urol Nephrol; 2007; 41(1):66-71. PubMed ID: 17366105
[TBL] [Abstract][Full Text] [Related]
4. Determining the importance of change in the overactive bladder questionnaire.
Coyne KS; Matza LS; Thompson CL; Kopp ZS; Khullar V
J Urol; 2006 Aug; 176(2):627-32; discussion 632. PubMed ID: 16813906
[TBL] [Abstract][Full Text] [Related]
5. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV
BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of health-related quality of life outcomes with darifenacin.
Abrams P; Kelleher C; Huels J; Quebe-Fehling E; Omar MA; Steel M
BJU Int; 2008 Jul; 102(2):208-13. PubMed ID: 18325056
[TBL] [Abstract][Full Text] [Related]
7. Validation of a patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire.
Clayson D; Wild D; Doll H; Keating K; Gondek K
BJU Int; 2005 Aug; 96(3):350-9. PubMed ID: 16042729
[TBL] [Abstract][Full Text] [Related]
8. Does condition-specific quality of life correlate with generic health-related quality of life and objective incontinence severity in women with stress urinary incontinence?
Oh SJ; Ku JH
Neurourol Urodyn; 2006; 25(4):324-9; discussion 330. PubMed ID: 16534817
[TBL] [Abstract][Full Text] [Related]
9. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.
Kelleher CJ; Cardozo L; Chapple CR; Haab F; Ridder AM
BJU Int; 2005 Jan; 95(1):81-5. PubMed ID: 15638900
[TBL] [Abstract][Full Text] [Related]
10. The patient's perspective: redefining end points.
Palmtag H
Urology; 2004 Dec; 64(6 Suppl 1):17-20. PubMed ID: 15621223
[TBL] [Abstract][Full Text] [Related]
11. Impact of fesoterodine on quality of life: pooled data from two randomized trials.
Kelleher CJ; Tubaro A; Wang JT; Kopp Z
BJU Int; 2008 Jul; 102(1):56-61. PubMed ID: 18564231
[TBL] [Abstract][Full Text] [Related]
12. Redefining response in overactive bladder syndrome.
Payne CK; Kelleher C
BJU Int; 2007 Jan; 99(1):101-6. PubMed ID: 17227496
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
14. [Assessments of quality of life in women with urinary incontinence using: King's Health Questionnaire and International Consultation on Incontinence Questionnaire-Short Form].
Ito H; Hagiwara M; Furuuchi T; Kanai K; Kodaira K; Ninomiya A; Nakamura S
Hinyokika Kiyo; 2010 May; 56(5):255-9. PubMed ID: 20519922
[TBL] [Abstract][Full Text] [Related]
15. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fesoterodine and tolterodine in patients with overactive bladder.
Chapple CR; Van Kerrebroeck PE; Jünemann KP; Wang JT; Brodsky M
BJU Int; 2008 Nov; 102(9):1128-32. PubMed ID: 18647298
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of urinary incontinence and its influence on the quality of life of Japanese women.
Azuma R; Murakami K; Iwamoto M; Tanaka M; Saita N; Abe Y
Nurs Health Sci; 2008 Jun; 10(2):151-8. PubMed ID: 18466389
[TBL] [Abstract][Full Text] [Related]
19. Impact of self-perceived bothersomeness on health-related quality of life in women with overactive bladder symptoms.
Oh SJ; Ku JH
Urol Int; 2007; 78(1):63-9. PubMed ID: 17192735
[TBL] [Abstract][Full Text] [Related]
20. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
